NYSE:ABBV

Abbvie Stock Predictions

Healthcare > Drug Manufacturers - General

Buy ABBV

*Your capital is at risk

$217.07

+1.64 (+0.761%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Abdu Pro @Abdu.1501	Dec 20, 2016	$62.15 -0.02%	$62.16	X	100.00%	10

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ABBVIE INC

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by